410 related articles for article (PubMed ID: 23318281)
41. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
42. Ultra-sensitive measurements of 11-Nor-δ(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer.
He X; Kozak M; Nimkar S
Anal Chem; 2012 Sep; 84(18):7643-7. PubMed ID: 22900543
[TBL] [Abstract][Full Text] [Related]
43. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
[TBL] [Abstract][Full Text] [Related]
44. Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015.
Lema-Atán JÁ; de Castro A; Lendoiro E; López-Rivadulla M; Cruz A
Drug Alcohol Depend; 2019 Feb; 195():106-113. PubMed ID: 30611978
[TBL] [Abstract][Full Text] [Related]
45. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
46. 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption.
Nadulski T; Bleeck S; Schräder J; Bork WR; Pragst F
Forensic Sci Int; 2010 Mar; 196(1-3):78-84. PubMed ID: 20074877
[TBL] [Abstract][Full Text] [Related]
47. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS.
Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T
Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485
[TBL] [Abstract][Full Text] [Related]
48. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
Rositano J; Harpas P; Kostakis C; Scott T
Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
[TBL] [Abstract][Full Text] [Related]
49. Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.
Barnes AJ; Scheidweiler KB; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):225-33. PubMed ID: 24622724
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous analysis of Δ(9)-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in hair without different sample preparation and derivatization by gas chromatography-tandem mass spectrometry.
Han E; Park Y; Kim E; In S; Yang W; Lee S; Choi H; Lee S; Chung H; Song JM
J Pharm Biomed Anal; 2011 Jul; 55(5):1096-103. PubMed ID: 21497038
[TBL] [Abstract][Full Text] [Related]
51. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".
Marchei E; Pellegrini M; Pacifici R; Palmi I; Lozano J; García-Algar O; Pichini S
Ther Drug Monit; 2006 Oct; 28(5):700-6. PubMed ID: 17038890
[TBL] [Abstract][Full Text] [Related]
52. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Himes SK; Chen X; Liu HF; Huestis MA
Anal Bioanal Chem; 2013 Jul; 405(18):6019-27. PubMed ID: 23681203
[TBL] [Abstract][Full Text] [Related]
53. Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid.
Toennes SW; Schneider K; Wunder C; Kauert GF; Moeller MR; Theunissen EL; Ramaekers JG
J Anal Toxicol; 2013 Apr; 37(3):152-8. PubMed ID: 23429905
[TBL] [Abstract][Full Text] [Related]
54. Detection and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in hair by GC/MS/MS in Negative Chemical Ionization mode (NCI) with a simple and rapid liquid/liquid extraction.
Minoli M; Angeli I; Ravelli A; Gigli F; Lodi F
Forensic Sci Int; 2012 May; 218(1-3):49-52. PubMed ID: 22036308
[TBL] [Abstract][Full Text] [Related]
55. Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs™ and application to real samples.
Fabresse N; Aouad H; Knapp A; Mayer C; Etting I; Larabi IA; Alvarez JC
Drug Test Anal; 2019 Jun; 11(6):824-832. PubMed ID: 30592550
[TBL] [Abstract][Full Text] [Related]
56. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
57. Testing human blood for cannabis by GC-MS.
Kintz P; Cirimele V
Biomed Chromatogr; 1997; 11(6):371-3. PubMed ID: 9413618
[TBL] [Abstract][Full Text] [Related]
58. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.
Quintela O; Crouch DJ; Andrenyak DM
J Anal Toxicol; 2006 Oct; 30(8):614-6. PubMed ID: 17132261
[TBL] [Abstract][Full Text] [Related]
59. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
[TBL] [Abstract][Full Text] [Related]
60. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.
Papafotiou K; Carter JD; Stough C
Forensic Sci Int; 2005 Dec; 155(2-3):172-8. PubMed ID: 16226154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
